Trade Pfizer Inc - PFE CFD

Trading Conditions
Spread0.11
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02629 %
(-$1.05)

Trade size with leverage ~ $5,000.00

Short position overnight funding adjustment ~ $4,000.00


-0.02629%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.004068 %
($0.16)

Trade size with leverage ~ $5,000.00

Short position overnight funding adjustment ~ $4,000.00


0.004068%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin20%
Stock exchangeUnited States of America
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close29.92
Open29.95
1-Year Change-19.58%
Day's Range29.4 - 30.03

Pfizer Company profile

Pfizer Inc. (PFE) is a New York-based multinational corporation engaged in the business of discovering, developing, producing and selling pharmaceuticals. It is one of the world's largest pharmaceutical companies and ranked 64 on the 2020 Fortune 500 list.

Pfizer shares are traded on the New York Stock Exchange under the ticker symbol PFE. The company is a constituent of the S&P 100 Index and S&P 500 Index (US500). Pfizer stock was also a constituent of the Dow Jones Industrial Average (US30) from 2004 to 2020. However, it was replaced by Amgen (AMGN) on August 31, 2020.

Get all the information you need on the PFE stock price today with Capital.com’s comprehensive chart.

The company was founded in 1849 in New York by two cousins, Charles Pfizer and Charles F Erhart. Already by 1906, Pfizer’s sales totalled $3.4m (£2.6m, €2.9m). Originally a manufacturer of fine chemicals, the business moved into pharmaceuticals in the second half of the 20th century.

Acquisitions have been one of the key growth strategies for Pfizer. Some of the firm’s major purchases include Warner-Lambert in 2000, Pharmacia in 2003, Wyeth in 2009, King Pharmaceuticals in 2010, Innopharma in 2014, and Medivation and Anacor Pharmaceuticals in 2016. In December 2018, the company announced a joint merger of its consumer healthcare division with the British pharma giant GlaxoSmithKline. The transaction closed in August 2019.

Today, Pfizer is headquartered in New York City, and its research HQ is in Groton, Connecticut. The company has research and development staff across the world to support its product pipeline. As well as numerous locations across the US, the company also has sites in Europe, India, Japan, Australia and Latin America.

Pfizer manufactures a broad range of medicines and vaccines for such therapeutic areas as immunology and inflammation, cardiovascular and metabolic diseases, oncology, neurological and psychiatric illnesses, and rare diseases. It is involved both in carrying out clinical trials and conducting research and development. Among its best-known products are the blockbuster drug Lipitor, the antibiotic Zithromax, and erectile dysfunction treatment Viagra.

In November 2020, Pfizer’s Covid-19 vaccine, developed with the German drugmaker BioNTech (BNTX), was found to be more than 90 per cent effective.

With Capital.com’s PFE chart you can not only quickly view the current Pfizer stock quote, but also trace the company’s shares value in historic terms.

In regard to the Pfizer Inc stock history, the company went public on June 22, 1942. The $5.9 million IPO was one of the largest of that year, with Pfizer offering shares at $24.75 apiece and reaching a market cap of $12.4 million on the first day of trading.

The business’ growth into one of the world's largest pharmaceutical corporations has generated hefty profits for its early investors. By 1998, when its famous Viagra medicine was launched in the US and Europe, Pfizer’s market cap had already soared by more than a million per cent from its IPO valuation.

The Pfizer Inc. share price had been on a general upward trend from the global financial crisis, when it fell as low as $12.30, up until November 2018, when it peaked at $46.30.

On March 23, 2020, the stock plunged to $27.88 per share amid the global economic uncertainty caused by the Covid-19 pandemic. The shares then quickly recovered to trade at $37-$39 throughout May, right before falling to $32 by the end of June. The Pfizer share value then inched higher to fluctuate in the $36-$39 range throughout August-October. The stock briefly broke out in early November after the company's Covid-19 vaccine, tested on 43,500 people, proved 90 per cent effective in a final-phase study.

You can go long or short on the company’s shares and trace all the latest ups and downs of the Pfizer stock price now using Capital.com’s proprietary trading platform.

Latest shares articles

Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
13:59, 8 July 2024
FOMC preview: Still expecting three rate cuts in 2024?
The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?
08:30, 11 June 2024
3 UK Stocks to Watch
Let’s take a look at three FTSE 100 heavyweights demonstrating high levels of relative strength.
12:41, 3 June 2024
Brilliant Basics - Part 2: Reversal Zones
Welcome to the second part of our educational series, Brilliant Basics. In this series, we'll explore how mastering the fundamentals lays the groundwork for achieving high-level performance in trading. Today, we focus on reversal zones, specifically the art of drawing support and resistance consistently across multiple timeframes.
11:17, 29 May 2024

Read our reviews to find out more about us

Read the feedback from our clients, whatever their experience level.

the simplicity and the pros of this app makes it amazing and a useful app

Hafsa

I have already tested many brokers and I can definitely say that Capital.com is the most professional trading tool.

PaCeKw

Capital.com is a good broker. I haven't had any problems with the trading platform but i qould advise that they add an option for either using lots or units.

Mr-phenom

I am in the first time but I look this website in YouTube there's a very good and safe platform for a traders Thinks for taking my opinion

MUHAMMAD JALIL MUHAMMAD ASGHAR

great UI, simple platform, low spreads, great coverage

Jihad Kattar

The videos are easy to follow, i get my profits and downs and understand the market now even more. This app is very well to understand. I would recommend this app to friends if they want to know.

Customer

Good and amazing app for trading and easy setups easy and smooth buy and sell amazing

QAISAR ALI

Excellent for people who would like to get and build all the experience needed to navigate to Stock Market.

Johnsy81

Overall my experience is very good with capital, the one best thing is they give you call support with most other broker apps don’t gives.

Ranjit

I have been usingCapital.comm platform for a year now. I did have some issues with using the platform in the earlier days but I received excellent support from Capital.com guiding me in the process of learning about the platform and put me on track. I am very happy with this platform and find it very easy to use for my trading needs. Capital.com also arranged a series of trading webinars last summer, which I attended and benefited from.

Dr Anjum Pervez

The best app for trade ever I tried to much trade app and this is the best

Moamen

Great website, easy to use and user friendly. Lot of markets to trade with. Good database of information and learning tutorials for beginner. Great customer support. I had some issues and they helped me solve them rapidly. One of the best broker, I recommend.

Nicolas Crampet

Trusted trading Platform Capital.com is the most trusted trading platform I ever experienced. Even without taking any demo,I have started funding and it’s going well. It is a very easy platform for the beginners and can have better trading experience by using this

JEYAKUMAR

great app, love the weekly and monthly insights, and review they send about my trading habits. spread for gold is usually 0.3 but at times fluctuates up to 0.9 this often makes it hard trading on the low time frames and not losing my position to spread even if my bias was correct, if the spread was better I'd give 5 star.

chris hoeben

Capital.com is the best broker of all time and I Should give it five stars but there is a small issue about execution of my orders through traddingview it is a bit slow. But the execution of orders directly from the capital.com App or Website is absolutely fast and apart from that everything is simple incredible.

IKOFO MOISE

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading